Your session is about to expire
← Back to Search
IPRP + rTMS for Chronic Pain
N/A
Recruiting
Led By Jillian V Miller, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Between the ages of 10-18 years
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this outcome will be measured at day 11.
Awards & highlights
Study Summary
This trial is testing whether adding brain stimulation to a 3-week pain intervention can help reduce pain symptoms in youth.
Who is the study for?
This trial is for young people aged 10-18 with severe chronic pain that disrupts their daily life and hasn't improved with standard pain treatments. They must understand the importance of actively managing their condition to restore function, but can't join if they have significant developmental delays, brain injuries, need opioid weaning or have untreated psychiatric illnesses.Check my eligibility
What is being tested?
The study tests whether adding Repeated Transcranial Magnetic Stimulation (rTMS) to an Intensive Pain Rehabilitation Program (IPRP) helps reduce chronic pain in youth. The rTMS targets a specific brain area affected by chronic pain and is given daily for three weeks alongside IPRP.See study design
What are the potential side effects?
While not specified here, common side effects of rTMS may include headache, scalp discomfort at the stimulation site, tingling or spasms of facial muscles, lightheadedness, and rare risk of seizure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 10 and 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ this outcome will be measured at day 11.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this outcome will be measured at day 11.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Anxiety
Brain imaging
Functional disability
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: rTMS + IPRPExperimental Treatment2 Interventions
25 youth aged 10-18 years with severe chronic pain will be invited to partake in the Intensive Pain Rehabilitation Program, where they will receive Repeated Transcranial Magnetic Stimulation as one of their treatment interventions.
Group II: IPRPActive Control1 Intervention
Youth within this arm will not be receiving the rTMS intervention. Rather, they will only be enrolled within the IPRP.
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,129 Total Patients Enrolled
6 Trials studying Chronic Pain
611 Patients Enrolled for Chronic Pain
Jillian V Miller, PhDPrincipal InvestigatorUniversity of Calgary
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a functional neurological disorder.I and my family agree to actively manage my recovery.I am a young person needing help to stop using opioids.I do not have severe medical or psychiatric conditions that would prevent rehabilitation.My pain severely affects my daily life and stops me from doing my usual activities.Pain treatments haven't helped me get back to my normal activities.I am between 10 and 18 years old.You have a major delay in development or a brain injury.
Research Study Groups:
This trial has the following groups:- Group 1: rTMS + IPRP
- Group 2: IPRP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this trial have an age limitation?
"In order to be included in this clinical trial, participants must fall between the ages of 10 and 18. For those younger than ten, there are 33 studies available while 362 trials exist for individuals aged 65 or over."
Answered by AI
How many participants are being admitted to this research endeavor?
"Affirmative. According to the clinicaltrials website, this experiment is actively accepting participants. It was initially posted on October 19th 2020 and its most recent update was made on May 16th 2022. 25 individuals are needed for 1 site in total."
Answered by AI
Who should consider participating in this medical study?
"The study is searching for 25 participants aged 10-18 with a history of chronic pain. Qualified candidates are welcome to join the trial."
Answered by AI
Are there any openings available to participate in the experiment?
"Affirmative. Information on clinicaltrials.gov states that this trial is actively seeking participants in its research endeavour, which was first posted on October 19th 2020 and most recently updated on May 16th 2022. The study requires 25 volunteers from one medical site to be enrolled for the experiment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger